# Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial

Study · id `cardio:ct-nct01559298` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01559298](<https://clinicaltrials.gov/study/NCT01559298>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01559298

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Valve and congenital heart disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

## Technical summary

Registry record NCT01559298. Randomized; no masking; primary purpose prevention. Start 2012-03 (actual); primary completion 2015-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 178 participants (enrolled count; ClinicalTrials.gov record NCT01559298, source copy `cardio:ctgov-nct01559298-2017-05-11`, retrieved 2026-10-26)
- Started: 2012-03 (actual) (ClinicalTrials.gov record NCT01559298, source copy `cardio:ctgov-nct01559298-2017-05-11`, retrieved 2026-10-26)
- Primary completion: 2015-03 (actual) (ClinicalTrials.gov record NCT01559298, source copy `cardio:ctgov-nct01559298-2017-05-11`, retrieved 2026-10-26)
- Completion: 2016-03 (actual) (ClinicalTrials.gov record NCT01559298, source copy `cardio:ctgov-nct01559298-2017-05-11`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01559298, source copy `cardio:ctgov-nct01559298-2017-05-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01559298-2017-05-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
- Acronym: ARTE
- Condition: Aortic Valve Disease
- Condition: Myocardial Infarction
- Condition: Stroke
- Intervention (Drug): Aspirin (80 mg/d) + clopidogrel (75 mg/d)
- Intervention (Drug): Aspirin
- Lead sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
- Lead sponsor class: OTHER
- Collaborator: Edwards Lifesciences
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (`cardio:org-centre-de-recherche-de-l-institut-universitaire-de-17cd1e`)
- Registry lists this organization as a collaborator: Edwards Lifesciences (`cardio:edwards-lifesciences`)

## Provenance

Content hash: f8e0a433c5fb1b21c233712c0a81ae7668d6207aff1f26d721c1f64336450805
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
